| TITLE |
DATE |
| StemCells, Inc. to Present at 2011 Stem Cell Meeting on the Mesa's Investor and Partnering Forum |
28-Nov-2011 |
| StemCells, Inc. Provides Business Update and Reports Third Quarter 2011 Financial Results |
1-Nov-2011 |
| StemCells, Inc. Announces Webcast to Discuss Third Quarter Financial Results and Business Update |
27-Oct-2011 |
| StemCells, Inc. to Feature at 2011 World Stem Cell Summit |
28-Sep-2011 |
| StemCells, Inc. CEO Martin McGlynn Featured on Wall Street Reporter |
23-Sep-2011 |
| StemCells, Inc. Announces World's First Neural Stem Cell Transplant in Spinal Cord Injury Patient |
22-Sep-2011 |
| StemCells, Inc. Awarded CIRM Planning Grant to Pursue Preclinical Development of HuCNS-SC Cells for Alzheimer's Disease |
1-Sep-2011 |
| Roth Capital Partners Initiates Research Coverage of StemCells, Inc. With Buy Recommendation |
26-Aug-2011 |
| StemCells, Inc. Reports Second Quarter Financial Results |
28-Jul-2011 |
| Stemcells, Inc. Announces Webcast to Discuss Second Quarter Financial Results and Business Update |
25-Jul-2011 |
| New Publication Validates Stemcells, Inc.'s SC Proven® Reagents For Automated Production and Cell-Based Screening |
22-Jul-2011 |
| Stemcells, Inc. Regains Compliance For Continued Nasdaq Global Market Listing |
21-Jul-2011 |
| StemCells, Inc. Relocates Corporate Headquarters and U.S. Research Labs |
18-Jul-2011 |
| StemCells, Inc. Announces Reverse Stock Split |
1-Jul-2011 |
| StemCells, Inc. to Present Clinical Evidence of Long-Term Survival of HuCNS-SC(R) Cells Following Completion of Immunosuppression Regimen |
15-Jun-2011 |
| StemCells, Inc. Reports First Quarter Financial Results and Announces Reduction in Force |
4-May-2011 |
| StemCells, Inc. Announces Webcast to Discuss First Quarter Financial Results and Business Update |
2-May-2011 |
| StemCells, Inc. Advances Alzheimer's Disease Program Through Collaboration With Leading Researcher |
18-Apr-2011 |
| StemCells, Inc. Discontinues Batten Disease Program |
8-Apr-2011 |
| StemCells, Inc. Adds Serum-Free and Animal Component-Free Cell Culture Supplements to Its SC Proven(R) Product Portfolio |
29-Mar-2011 |
| StemCells, Inc. Further Expands SC Proven(R) Product Portfolio With New Line of Purified Whole Cell Lysate Reagents |
22-Mar-2011 |
| StemCells, Inc. Initiates World's First Neural Stem Cell Trial in Spinal Cord Injury |
14-Mar-2011 |
| StemCells, Inc. Reports Fourth Quarter and Fiscal 2010 Financial Results and Business Highlights |
11-Mar-2011 |
| StemCells, Inc. to Present at ROTH Capital Partners Growth Conference |
8-Mar-2011 |
| StemCells, Inc. to Present at New York Stem Cell Summit |
23-Feb-2011 |
| StemCells, Inc. Completes Dosing in Second Trial of HuCNS-SC(R) Neural Stem Cells |
17-Feb-2011 |
| StemCells, Inc. to Present at BIO CEO & Investor Conference |
8-Feb-2011 |
| StemCells, Inc. Broadens Its SC Proven(R) Product Portfolio With Launch of Two Additional Human Cell Detection Antibodies |
19-Jan-2011 |
| StemCells, Inc. Closes $10 Million Common Stock Financing |
11-Jan-2011 |
| StemCells, Inc. Announces $10 Million Common Stock Financing |
7-Jan-2011 |
 |
